Escherichia coli is the cause of more than 80% of urinary tract infections in all age groups and can lead to renal failure if remained untreated for a long time (
2,
21). Various virulence factors can be attributed to UPEC pathogenicity (
5). Better knowledge of the properties of virulence and its antibiotic resistance pattern helps clinicians to anticipate the development of infection in the patients. Surface virulence factors of UPEC including adhesions, are responsible for colonization of bacteria in the urinary tract. The current study results showed that 16.6 % of UPEC isolates carried
pap gene. The frequency of
pap gene in UPEC isolates in the present study was lower compared to those of found in Brazil, Tunisia, China, (
5,
6,
22), but is in agreement with the results of studies conducted by Usein et al. and Santo et al. who reported the gene frequencies of 17% and 14%, respectively (
14,
21).
According to the literature, the frequency of
pap gene can vary from 0% to 77% (
5,
8,
10,
11). The diversity in frequency of
pap gene among different studies can be due to the fact that UPEC strains utilize a variety of adhesins to bind to the urinary epithelial cells, and start the infection. Hence, the strains lacking the
pap operon may use other adhesins encoding operons such as
afa, and
sfa for binding. The PAI marker showed a frequency of 61.3% in the current study. Johnson et al. (
10), reported a frequency of 71% for PAI - markers among UPEC isolated from the patients with urosepsis in the USA. In a survey conducted by Navidinia et al. (
23), a prevalence of 89% was documented for these markers in UPEC strains. It is documented that the pathogenicity islands (PAIs) capable of horizontal virulence genes transfer between species; therefore, a frequency of 61.3% for PAI markers in UPEC strains isolated from hospitalized patients is notable.
Usually, the invasive pathogens are highly resistant to the lethal activity of serum and the role of traT
- protein in resistance of bacteria to serum is very important. The current study results showed that 74% of UPEC isolates contained
traT gene. A study in the USA on blood samples from patients with urosepsis showed that
traT is a common gene among immune-compromised patients (
10). Oliveira et al. (
11) showed that 76%of the urine samples were contaminated with multidrug-resistant bacteria carrying
traT gene and Kudinha et al. reported a frequency of 77% (
2) for
traT gene among
E. coli strains isolated from patients with cystitis. These results are compatible with those of the current study, which suggest that the
traT, as a common and important virulence factor, could be considered as a target for therapeutic interventions. In the current study, eight distinct patterns were identified among the UPEC strains; whereas, high heterogeneity of the virulence genes compositions were documented in other studies (
10,
11).
Urinary tract infection is one of the most common bacterial infections and increased antibiotic resistance has complicated the treatment of such infections. Seventy-four percent of UPEC strains demonstrated multidrug-resistance phenotype and showed resistance to more than three of the tested antimicrobials in the present study. High frequency of antibiotic resistance among UPEC strains were reported in previous studies in Iran (
8,
24). Johnson et al. (
10) reported 50% multidrug-resistant
E. coli among the species isolated from urine specimens. Finding of the current study showed a high rate of resistance to ampicillin, cotrimoxazole, nalidixic acid and ciprofloxacin. Studies from other countries also reported the high frequency of resistant to antibiotics in
E. coli strains isolated from urine samples (
8,
25-
27).
Treatment failure with the first line drugs like ampicillin, cotrimoxazole, nalidixic acid has led to excessive prescription of floroquinolons and extended spectrum cephalosporins for treatment of wide range of infections including UTI, gastroenteritis, lower respiratory tract infection, and other infections in Iran. Floroquinolons, including ciprofloxacin, are not recommended as first-line antibiotics for the treatment of UTI, but they are generally advised for the empirical therapies. Regarding the results of the current study, 61.3% resistance to ciprofloxacin, which may result from discriminate use of this antibiotic in Iran, is considerable. Also, resistance to third generation cephalosporins, such as ceftazidim, and ceftriaxone was high in the present study. These results corresponded to other studies conducted by Rezaee et al. (
24) and Mukherjee et al. (
27) who reported 46.4% and 55% resistance in
E. coli to ceftazidime, respectively; but are in contrast with Oliveira et al. (
11) findings who documented 1% ceftriaxone-resistant UPEC.
Resistance to extended spectrum cephalosporins has increasing considerably in developing countries like Iran, and it was primarily due to the ample and discriminate use of antibiotics in these countries. In the present study, 16% of the UPEC strains showed resistance to amoxicillin-clavulanic acid. Similar results obtained from other studies (
28,
29). In Mexico, the rate of resistance to amoxicillin-clavulanic acid in
E. coli strains isolated from outpatients with uncomplicated UTI was 19.6% (
28). In Another study on community-acquired urinary tract infections in Italy, the rate of amoxicillin-clavulanate-resistant
E. coli isolates was 18.2% (
29). Because of the relatively low antibiotic resistance rate, this drug can be recommended for the treatment of urinary tract infections. According to the findings of the current study, UPEC strains showed high sensitivity to nitrofurantoin, which confirms the results of other studies (
30,
31). Sensitivity to nitrofurantoin may result from decreasing the use of this drug (
32). As nitrofurantoin is unable to create appropriate level in blood flow, it is used only for treatment of uncomplicated UTIs, and not recommended for complicated UTI and systemic involvements.
The present study showed high resistance to aztreonam, which was in accordance with the findings of Navidinia et al. who demonstrated that 78% of UPEC strains were resistant to aztreonam (
23). High resistance to aztreonam was reported by Pobiega et al. among the extended-spectrum β-lactamases (ESBL)-producing
E. coli strains (
33). Aztreonam is not used in Iran. Resistance against aztreonam may be associated with the production of ESBL enzymes by ESBL-producing strains, which breakdown beta-lactam ring in this antibiotic. Identifying one imipenem resistant UPEC and four isolates with reduced susceptibility to this antibiotic were other interesting findings of the current study. Most studies have reported 100% sensitivity to imipenem (
1,
31), but the resistance to imipenem in
E. coli strains isolated from urine samples was indicated in other studies (
34). Rezaee et al. reported 1.4% resistance to imipenem among
E. coli isolates (
24). As carbapenems are advising for the treatment of severe infections caused by ESBL-producing
E. coli, emerging resistance to this antibiotic is a place of major concern in treating infections caused by such resistant bacteria.
In conclusion, finding of the current study showed that the traT gene and PAI markers were highly prevalent among UPEC strains isolated from hospitalized patients in Kashan; hence, they could be considered as useful targets for prophylactic interventions. Also, in the current study high resistance was observed against the antibiotics widely used for the treatment of urinary tract infection; therefore, to reach better therapeutic outcomes, empiric treatment regimens have to be modified.